Optical Genome Mapping Market Set to Skyrocket from USD 108.3 Mn in 2023 to USD 772.7 Mn by 2032

DENVER, Del. - Oct. 3, 2025 - PRLog -- Acumen Research And Consulting has released its in-depth Optical Genome Mapping Market Report, offering comprehensive insights into the Optical Genome Mapping Market Size, Share, Growth, Analysis, and Trends over the period 2024-2032. According to the report, global market is poised for exponential growth driven by demand for advanced genomic tools and increasing applications in diagnostics, research, and biotechnology.

Optical Genome Mapping Market Report Statistics

• Market Size & Forecast: Optical Genome Mapping Market Size was valued at USD 108.3 million in 2023 and is projected to reach USD 772.7 million by 2032, registering a robust CAGR of 24.9% from 2024 to 2032.
• Regional Insights & Market Share: North America led the market in 2023 with approximately 43% share, valued at USD 46.6 million. Asia-Pacific is forecasted to grow at the fastest rate, with a CAGR of over 25% during 2024-2032.
• Segment Shares by Product & Solution: Software and services segment held nearly 39% market share in 2023. Among solutions, structural variant detection was dominant, representing around 48% share.

Optical Genome Mapping Market Trends, Growth & Analysis

Optical Genome Mapping Market Trends highlight rising adoption of OGM for detecting large-scale genomic rearrangements—such as insertions, deletions, and inversions—that traditional sequencing methods may overlook. Growing use in personalized medicine, diagnostics, and drug discovery is fuelling Optical Genome Mapping Market Growth.

Get Free Sample Report: https://www.acumenresearchandconsulting.com/request-sample/3796

Key drivers identified in the Optical Genome Mapping Market Analysis include:

• Increasing demand for precise detection of structural variants
• Rising prevalence of genetic and rare diseases
• Expanding applications in research and pharmaceutical R&D
• Government funding and investment in genomics

Regional Outlook

Optical Genome Mapping Market Share remains concentrated in North America, driven by advanced healthcare infrastructure, funding for genomic research, and rapid adoption of cutting-edge technologies. Asia-Pacific is projected to be the fastest-growing market, supported by increasing R&D investments, favorable government initiatives, and growing demand for personalized medicine.

Key Players:

• Bionano Genomics
• Hofkens Lab
• Nucleome Informatics
• Genohub Inc.
• Praxis Genomics LLC
• PerkinElmer Genomics
• SourceBio International
• Cerba HealthCare
• INRAE OpGen Inc.

Why This Report Matters

With Optical Genome Mapping Market projected to grow nearly sevenfold, from USD 108.3 million in 2023 to USD 772.7 million by 2032, this report is vital for:

• Genomics companies and diagnostic labs advancing precision medicine
• Pharmaceutical and biotech firms integrating structural variant detection into R&D
• Academic and research institutes expanding genomic research capabilities
• Investors targeting high-growth healthcare technology markets

Read Full Analysis: https://www.acumenresearchandconsulting.com/optical-genome-mapping-market